157 related articles for article (PubMed ID: 23378912)
1. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection.
Abujarour R; Valamehr B; Robinson M; Rezner B; Vranceanu F; Flynn P
Sci Rep; 2013; 3():1179. PubMed ID: 23378912
[TBL] [Abstract][Full Text] [Related]
2. Scalable expansion of human induced pluripotent stem cells in the defined xeno-free E8 medium under adherent and suspension culture conditions.
Wang Y; Chou BK; Dowey S; He C; Gerecht S; Cheng L
Stem Cell Res; 2013 Nov; 11(3):1103-16. PubMed ID: 23973800
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Reprogramming Efficiency and Pluripotency of the Established Human iPSCS by Pluripotency Markers.
Cevallos RR; Hossain ME; Zhang R; Hu K
Methods Mol Biol; 2021; 2239():235-249. PubMed ID: 33226623
[TBL] [Abstract][Full Text] [Related]
4. Mass cytometry-based single-cell analysis of human stem cell reprogramming uncovers differential regulation of specific pluripotency markers.
Im I; Son YS; Jung KB; Kang I; Teh BE; Lee KB; Son MY; Kim J
J Biol Chem; 2019 Dec; 294(49):18547-18556. PubMed ID: 31570522
[TBL] [Abstract][Full Text] [Related]
5. Induced pluripotent stem cells from GMP-grade hematopoietic progenitor cells and mononuclear myeloid cells.
Ohmine S; Dietz AB; Deeds MC; Hartjes KA; Miller DR; Thatava T; Sakuma T; Kudva YC; Ikeda Y
Stem Cell Res Ther; 2011 Nov; 2(6):46. PubMed ID: 22088171
[TBL] [Abstract][Full Text] [Related]
6. Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.
Slamecka J; Salimova L; McClellan S; van Kelle M; Kehl D; Laurini J; Cinelli P; Owen L; Hoerstrup SP; Weber B
Cell Cycle; 2016; 15(2):234-49. PubMed ID: 26654216
[TBL] [Abstract][Full Text] [Related]
7. Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.
Chen HF; Chuang CY; Lee WC; Huang HP; Wu HC; Ho HN; Chen YJ; Kuo HC
Stem Cell Rev Rep; 2011 Sep; 7(3):722-35. PubMed ID: 21305366
[TBL] [Abstract][Full Text] [Related]
8. Derivation of three clones from human embryonic stem cell lines by FACS sorting and their characterization.
Sidhu KS; Tuch BE
Stem Cells Dev; 2006 Feb; 15(1):61-9. PubMed ID: 16522163
[TBL] [Abstract][Full Text] [Related]
9. Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig.
Park JK; Kim HS; Uh KJ; Choi KH; Kim HM; Lee T; Yang BC; Kim HJ; Ka HH; Kim H; Lee CK
PLoS One; 2013; 8(1):e52481. PubMed ID: 23326334
[TBL] [Abstract][Full Text] [Related]
10. Identification of unsafe human induced pluripotent stem cell lines using a robust surrogate assay for pluripotency.
Polanco JC; Ho MS; Wang B; Zhou Q; Wolvetang E; Mason E; Wells CA; Kolle G; Grimmond SM; Bertoncello I; O'Brien C; Laslett AL
Stem Cells; 2013 Aug; 31(8):1498-510. PubMed ID: 23728894
[TBL] [Abstract][Full Text] [Related]
11. Nuclear reprogramming with a non-integrating human RNA virus.
Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
[TBL] [Abstract][Full Text] [Related]
12. Induced pluripotent stem cell lines derived from human gingival fibroblasts and periodontal ligament fibroblasts.
Wada N; Wang B; Lin NH; Laslett AL; Gronthos S; Bartold PM
J Periodontal Res; 2011 Aug; 46(4):438-47. PubMed ID: 21443752
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of human-induced pluripotent stem cells derived from bone marrow cells, hair keratinocytes, and skin fibroblasts.
Streckfuss-Bömeke K; Wolf F; Azizian A; Stauske M; Tiburcy M; Wagner S; Hübscher D; Dressel R; Chen S; Jende J; Wulf G; Lorenz V; Schön MP; Maier LS; Zimmermann WH; Hasenfuss G; Guan K
Eur Heart J; 2013 Sep; 34(33):2618-29. PubMed ID: 22798560
[TBL] [Abstract][Full Text] [Related]
14. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
[TBL] [Abstract][Full Text] [Related]
15. Generation of OCT4-EGFP, NANOG-tdTomato dual reporter human induced pluripotent stem cell line, KKUi001-A, using the CRISPR/Cas9 system.
Lee M; Choi NY; Park S; Bang JS; Lee Y; Jeong D; Ham S; Lim S; Kim KH; Ko K
Stem Cell Res; 2020 Oct; 48():101943. PubMed ID: 32777770
[TBL] [Abstract][Full Text] [Related]
16. Self-renewal and differentiation capabilities are variable between human embryonic stem cell lines I3, I6 and BG01V.
Tavakoli T; Xu X; Derby E; Serebryakova Y; Reid Y; Rao MS; Mattson MP; Ma W
BMC Cell Biol; 2009 Jun; 10():44. PubMed ID: 19500347
[TBL] [Abstract][Full Text] [Related]
17. piggyBac Transposon Mediated Reprogramming and Flow Cytometry Analysis of CD44 and ICAM1 Cell-Surface Marker Changes.
Brightwell S; Kaji K
Methods Mol Biol; 2016; 1357():285-93. PubMed ID: 25410291
[TBL] [Abstract][Full Text] [Related]
18. Improved methods for reprogramming human dermal fibroblasts using fluorescence activated cell sorting.
Kahler DJ; Ahmad FS; Ritz A; Hua H; Moroziewicz DN; Sproul AA; Dusenberry CR; Shang L; Paull D; Zimmer M; Weiss KA; Egli D; Noggle SA
PLoS One; 2013; 8(3):e59867. PubMed ID: 23555815
[TBL] [Abstract][Full Text] [Related]
19. Human Adipose-Derived Pericytes: Biological Characterization and Reprogramming into Induced Pluripotent Stem Cells.
Ahmed TA; Shousha WG; Abdo SM; Mohamed IK; El-Badri N
Cell Physiol Biochem; 2020 Apr; 54(2):271-286. PubMed ID: 32233339
[TBL] [Abstract][Full Text] [Related]
20. Identification of Oct4-activating compounds that enhance reprogramming efficiency.
Li W; Tian E; Chen ZX; Sun G; Ye P; Yang S; Lu D; Xie J; Ho TV; Tsark WM; Wang C; Horne DA; Riggs AD; Yip ML; Shi Y
Proc Natl Acad Sci U S A; 2012 Dec; 109(51):20853-8. PubMed ID: 23213213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
